SRC
KERX
Shufro Rose & Co’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-88,800
| Closed | -$302K | – | 310 |
|
|
2018
Q3 | $302K | Sell |
88,800
-3,000
| -3% | -$10.2K | 0.03% | 227 |
|
|
2018
Q2 | $345K | Buy |
91,800
+19,000
| +26% | +$71.4K | 0.03% | 209 |
|
|
2018
Q1 | $298K | Buy |
72,800
+5,000
| +7% | +$20.5K | 0.03% | 227 |
|
|
2017
Q4 | $315K | Sell |
67,800
-2,600
| -4% | -$12.1K | 0.03% | 216 |
|
|
2017
Q3 | $500K | Hold |
70,400
| – | – | 0.05% | 162 |
|
|
2017
Q2 | $509K | Sell |
70,400
-2,800
| -4% | -$20.2K | 0.05% | 155 |
|
|
2017
Q1 | $451K | Buy |
73,200
+500
| +0.7% | +$3.08K | 0.05% | 163 |
|
|
2016
Q4 | $426K | Buy |
72,700
+500
| +0.7% | +$2.93K | 0.05% | 169 |
|
|
2016
Q3 | $383K | Sell |
72,200
-5,800
| -7% | -$30.8K | 0.04% | 179 |
|
|
2016
Q2 | $516K | Buy |
78,000
+22,900
| +42% | +$151K | 0.06% | 155 |
|
|
2016
Q1 | $257K | Sell |
55,100
-3,500
| -6% | -$16.3K | 0.03% | 220 |
|
|
2015
Q4 | $295K | Sell |
58,600
-2,800
| -5% | -$14.1K | 0.03% | 193 |
|
|
2015
Q3 | $216K | Buy |
61,400
+26,700
| +77% | +$93.9K | 0.03% | 219 |
|
|
2015
Q2 | $346K | Buy |
+34,700
| New | +$346K | 0.04% | 190 |
|